Benzene is approaching $5 a gallon, caprolactam is up $380/mt in a single week. Brent is above $100 on a Hormuz stalemate that can be
adequately described as Schrödinger's Strait, both open and closed at the same time, depending on the observer's view and agenda. Every
trade publication has covered the feedstock side of this cycle, and they should, as it's quite serious.
But while everyone was watching upstream, something else happened in the PA66 and PA6 markets. Something quieter, more structural,
and in some ways more consequential for the buyers who haven't been paying attention.
Three events. Sixty days. Same supply base.
On April 30, Lone Star Funds completed its acquisition of RadiciGroup's High Performance Polymers and Specialty Chemicals businesses,
a broad PA6, PA66, and specialty nylon platform with global reach. On May 12, Lone Star completed its acquisition of DOMO Engineered
Materials, another significant PA6 and PA66 producer. And in between, Celanese announced it is closing its 55,000-metric-ton-per-year PA66
polymerization unit in Singapore after July 2026, while reducing operating rates at facilities in Richmond, Virginia, and Parkersburg, West Virginia.
None of these made front-page headlines. None of them are feedstock stories. All three are resin procurement stories, and they matter more to
what PA66 buyers pay in Q3 and Q4 than anything currently happening at the Strait of Hormuz.
The Lone Star roll-up of DOMO and RadiciGroup is the same dynamic. These were independent producers that buyers could play against each
other in negotiations. Now they're a single platform. The supplier list looks the same on paper. The competitive pressure between those two
names will disappear.
That's not a crisis. A better-capitalized, more operationally stable nylon supplier has real value in a volatile market. But buyers who built their PA66
or PA6 sourcing strategy on a two-supplier model with DOMO and RadiciGroup as competing legs need to revisit that model now and must not wait
until after it's already changed the negotiation.
The consolidation is a structural shift that plays out over time. The Celanese Singapore closure is more immediate. It is announced. It is dated. It is
this quarter.
55,000 metric tons per year of PA66 polymerization capacity doesn't move to another plant. It doesn't get replaced by import supply next month. It
exits the global supply pool in July, during a period when benzene and caprolactam are both elevated, and demand, while mixed, remains supported
in automotive and industrial end markets.
The buyers who come out of the second half of 2026 in a strong PA66 position are the ones acting on this now, not after the Singapore unit goes offline.
That means auditing H2 volume positions against open contracts this week. It means rebuilding the alternates map. Ask yourself, who qualifies as the
second-leg supplier now that the Lone Star platform has consolidated DOMO and RadiciGroup? BASF, Ascend, AdvanSix, and Lanxess all deserve a
fresh look. And it means engaging suppliers on H2 pricing before August, when the leverage dynamic looks different.